RARRES2 and breast carcinoma: Antitumor activities of Chemerin have been identified in a murine model of breast cancer, where it binds to its receptor ChemR23/CMKLR1 and inhibits neovascularization, thereby suppressing growth and invasion of breast cancer cells (148).